Spanish beauty group Puig delivered a third-quarter sales update that came in ahead of market expectations, prompting Berenberg, a European investment bank, to raise its price target on the stock to €18.20. The move reflects growing confidence in the company's makeup segment, which got a notable boost from its Charlotte Tilbury brand.
Puig reported like-for-like growth of 5.6% for the third quarter, a figure that landed 70 basis points (0.7 percentage points) above the consensus estimate among analysts. Like-for-like growth strips out the effects of currency fluctuations, acquisitions and divestitures, giving a clearer picture of underlying demand. A basis point is one-hundredth of a percentage point, so a 70-basis-point beat is a meaningful margin of outperformance for a consumer company.
What's driving the beat?
The standout driver was makeup, where Charlotte Tilbury—a premium cosmetics brand Puig acquired in 2020—continued to perform strongly. While the brief doesn't break out exact figures for the brand, its contribution was enough to lift the overall makeup category and help Puig exceed expectations.
Puig is one of the world's largest fragrance and fashion groups, with a portfolio that includes well-known names like Jean Paul Gaultier, Paco Rabanne, and Carolina Herrera, alongside Charlotte Tilbury. The company went public in May 2024, listing on the Spanish stock exchange in one of Europe's biggest IPOs of that year. Since then, investors have watched its quarterly numbers closely for signs that the beauty market remains resilient despite broader economic uncertainty.
The beauty industry has generally held up better than many other consumer sectors, as people continue to spend on smaller indulgences like cosmetics and fragrances even when they cut back on bigger purchases. However, growth has slowed from the post-pandemic boom, and companies like Puig have had to rely on brand strength and new product launches to keep momentum.
Berenberg's revised outlook
Berenberg's decision to lift its price target to €18.20 from a previous level (not specified in the brief) signals that the bank sees more upside in Puig's shares. Price targets are analysts' estimates of where a stock could trade in the next 12 months or so, based on their earnings forecasts and valuation models. A target above the current trading price suggests the analyst believes the stock is undervalued.
The bank's move is consistent with its broader coverage of European consumer and healthcare names. For instance, Berenberg has recently expressed positive views on other companies in its coverage, such as Fresnillo's silver production and ABB's data center demand. While those are in different sectors, the pattern shows the bank is willing to adjust targets when results come in better than expected.
It's worth noting that a single analyst's price target is not a guarantee of future performance. Other banks may have different views, and the actual share price will depend on a wide range of factors, including broader market conditions, consumer sentiment, and company-specific developments.
What it means for investors
For everyday investors, the key takeaway is that Puig's core business is growing faster than many analysts anticipated. That's a positive signal for the company's fundamentals, but it doesn't mean the stock is a guaranteed winner. Here are a few things to consider:
- Growth is slowing but still positive: A 5.6% like-for-like growth rate is respectable for a large consumer company, especially in a climate where many peers are seeing flat or negative volumes. The beat suggests Puig is gaining market share or benefiting from strong brand loyalty.
- Makeup is a bright spot: Charlotte Tilbury's performance is a reminder that premium brands can thrive even in tough economic times. If you're invested in Puig, watch for continued strength in this segment.
- Analyst targets are just opinions: Berenberg's €18.20 target is one view. It's useful as a data point, but you should look at the broader consensus and the company's own guidance before making decisions.
Puig's results also come against a backdrop of mixed economic data in Europe. The eurozone has seen growth cool recently, with France slipping back into contraction. That could weigh on consumer spending in the region, but beauty products have historically been less sensitive to economic downturns than big-ticket items.
Investors will likely watch Puig's next earnings report for signs that the momentum can be sustained. The company's ability to keep innovating and expanding its brand portfolio will be key. For now, the market has taken the latest update as a positive, and the stock may see some upward pressure as analysts adjust their models.
As always, it's important to remember that past performance doesn't guarantee future results. A single quarter's beat is encouraging, but it's just one piece of the puzzle. Diversification and a long-term perspective remain the cornerstones of sound investing.
